Profile cover photo
Profile photo
Wolf Greenfield & Sacks
3 followers
3 followers
About
Wolf Greenfield & Sacks's posts

"The decision marks a shift in patent venue and likely will result in an exodus of cases from the Eastern District of Texas to other popular jurisdictions such as the District of Delaware (where many patent litigation defendants are incorporated) or the Northern District of California (where many patent litigation defendants have established places of business)."

Post has attachment
Who knows whether something is a "printed publication?" http://hubs.ly/H07ypRK0

Post has attachment
Wolf Greenfield is excited to welcome a new shareholder to its Biotechnology Group.

Post has attachment
Last call: Join our IP litigation panel discussion on 5/25 with counsel from Sony, Straumann and Wolf Greenfield to learn about techniques companies in any industry can use to achieve successful results in patent litigation while keeping fees reasonable. http://hubs.ly/H07wxGg0 

Post has attachment
Functional Claiming at the PTAB: A Lose-Lose Situation? 

Post has attachment

Post has attachment
Charlie Steenburg sheds light on the oral arguments in Amgen v. Sandoz, as published by Life Science Leader. 

Post has attachment
Wolf Greenfield is excited to welcome Michael Twomey as a shareholder in our Biotechnology Group. Michael was recommended in the 2016 edition of The Legal 500 United States for intellectual property: patents: portfolio management and licensing, and was recognized as a "Life Sciences Star" for outstanding intellectual property work in the 2012-2016 editions of LMG Life Sciences. Read more.

Post has attachment
As the differences between utility and design patents can play an enormous role in your company’s success, diversifying your IP investment with design protection may be a strategic move worth making. 

Post has attachment
Wait while more posts are being loaded